ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10286
Vaccine NameV-SARS
Disease NameCOVID-19
Disease ClassificationRespiratory
Virus NameSARS-CoV-2 virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypePlasma based
Vaccine StatusPhase 2
ManufacturerImmunitor LLC
Year of Manufacturing2020
Manufacturing CountryCanada
Age18 - 65 years
DosageNA
Administration RouteOral
AdjuvantNA
Target StrainPooled plasma of COVID-19 patients
DescriptionNA
Approving OrganisationNA
Collaborating OrganisationNA
Other CountriesNA
Trade NameNA
PMIDNA
Clinical Trial IDNCT04380532
Reference Linkhttps://clinicaltrials.gov/show/NCT04380532
Additional LinksNA